AFC-HD AMS Life ScienceAFC-HD AMS Life Science Co.,Ltd.2927東証スタンダード食料品FY ending Aug 2025, consolidated, J-GAAP

AFC-HD AMS Life Science FY ending Aug 2025 results

About 61% of AFC-HD AMS Life Science's sales come from Health care, with Department store business and Real Estate and Consignment Business making up much of the rest.

Out of every ¥100 of sales, about ¥7 is left as operating profit.

Revenue changed +8.2% from the prior year, operating profit +25.8%.

Revenue and profit pattern

Revenue and profit upProfit grew faster

Revenue +8.2% · profit +25.8%, calculated from disclosed figures.

Operating leverage: 3.15× (profit growth ÷ revenue growth)

What changed from last year

FY ending Aug 2024 → FY ending Aug 2025

Revenue: +8.2%¥30.2B → ¥32.7B
Gross profit: +7.3%¥10.5B → ¥11.3B
Operating income: +25.8%¥1.92B → ¥2.41B
Net income attributable to owners: +15.7%¥1.25B → ¥1.45B
Operating cash flow: +16.0%¥1.54B → ¥1.79B
Free cash flow: Loss-¥1.87B → -¥1.75B

Where the money goes

FY ending Aug 2024 → FY ending Aug 2025

※ Segment revenues include inter-segment sales and are scaled to consolidated revenue

Where ¥100 of sales goes

For every ¥100 AFC-HD AMS Life Science sells, how much goes where, and how much is kept.

FY ending Aug 2025

Cost of sales: ¥66
SG&A: ¥27
Operating profit: ¥7
Net profit kept: ¥4

Annual margin trends

Gross margin34.5%

Operating margin7.4%

Net margin4.4%

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Which businesses earn the money

Revenue by business segment, and the profit each one keeps.

FY ending Aug 2025

Health care¥18.9B
61%
Op. margin 13.0%Industry: Cosmetics
Department store business¥4.61B
15%
Op. margin 1.3%Industry: Department Stores
Real Estate and Consignment Business¥2.66B
9%
Op. margin 0.6%Industry: Real Estate Development & Leasing
Medical products¥2.47B
8%
Op. margin 9.3%Industry: Pharmaceuticals
Food service business¥2.36B
8%
Op. margin -3.2%Industry: Restaurants & Pubs

Profit by segment

※ Segment figures include inter-segment sales and do not sum to the company total

Sources

Show source documents (6)

EDINET (FSA Japan)
有価証券報告書－第45期(2024/09/01－2025/08/31)
ID S100X6W82025-11-26Open
EDINET (FSA Japan)
有価証券報告書－第44期(2023/09/01－2024/08/31)
ID S100UT2C2024-11-27Open
EDINET (FSA Japan)
有価証券報告書－第43期(2022/09/01－2023/08/31)
ID S100SD2P2023-11-28Open
EDINET (FSA Japan)
有価証券報告書－第42期(令和3年9月1日－令和4年8月31日)
ID S100PQ002022-11-30Open
EDINET (FSA Japan)
訂正有価証券報告書－第41期(令和2年9月1日－令和3年8月31日)
ID S100N0TK2021-12-08Open
EDINET (FSA Japan)
有価証券報告書－第40期(令和1年9月1日－令和2年8月31日)
ID S100K8NO2020-11-25Open

Extracted from XBRL: 55 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open Markdown Share on X Save image